PhRMA, BIO, MIWG File Petition To Block FDA's Intended Use Rule

Three major industry groups are attempting to indefinitely halt FDA's controversial intended use final rule, which they say violates the Administrative Procedure Act, creates a "new and unjustified legal standard" for determining intended use, and could impact public health by limiting scientific discussion about medical products. The groups filed a petition asking the agency to revert back to less controversial language included in the 2015 proposed rule. The rule was originally slated to go into effect Feb. 8, but was...